NHERF4
Na(+)/H(+) exchange regulatory cofactor NHE-RF4
Also known as: FLJ22756, IKEPP, NHRF4_HUMAN, PDZD3, PDZK2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86UT5
- Gene
- NHERF4
- Ensembl
- ENSG00000172367
- Chromosome
- 11
- Canonical length
- 571 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Guanylyl cyclase C (GCC, or GUCY2C; MIM 601330) produces cGMP following the binding of either endogenous ligands or heat-stable enterotoxins secreted by E. coli and other enteric bacteria. Activation of GCC initiates a signaling cascade that leads to phosphorylation of the cystic fibrosis transmembrane conductance regulator (CFTR; MIM 602421), followed by a net efflux of ions and water into the intestinal lumen. IKEPP is a regulatory protein that associates with GCC and regulates the amount of cGMP produced following receptor stimulation (Scott et al., 2002 [PubMed 11950846]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
571 residues, UniProt reviewed canonical sequence.
>Q86UT5|NHERF4
1 MVTPSPPGNH SLSLEAPRLH TASDLLGNHS LGLPLITALV GSRDRRGRVF SPVPVPLPTN
61 PTTQHPTRQK LPSTLSGHRV CQAHGEPVLG LCPLLPLFCC PPHPPDPWSL ERPRFCLLSK
121 EEGKSFGFHL QQELGRAGHV VCRVDPGTSA QRQGLQEGDR ILAVNNDVVE HEDYAVVVRR
181 IRASSPRVLL TVLARHAHDV ARAQLGEDAH LCPTLGPGVR PRLCHIVKDE GGFGFSVTHG
241 NQGPFWLVLS TGGAAERAGV PPGARLLEVN GVSVEKFTHN QLTRKLWQSG QQVTLLVAGP
301 EVEEQCRQLG LPLAAPLAEG WALPTKPRCL HLEKGPQGFG FLLREEKGLD GRPGQFLWEV
361 DPGLPAKKAG MQAGDRLVAV AGESVEGLGH EETVSRIQGQ GSCVSLTVVD PEADRFFSMV
421 RLSPLLFLEN TEAPASPRGS SSASLVETED PSLEDTSVPS VPLGSRQCFL YPGPGGSYGF
481 RLSCVASGPR LFISQVTPGG SAARAGLQVG DVILEVNGYP VGGQNDLERL QQLPEAEPPL
541 CLKLAARSLR GLEAWIPPGA AEDWALASDL LLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NHERF4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 18 nTPM
Expression across tissuesHPA
Tissue
- small intestine: 18 nTPM
- kidney: 18 nTPM
- duodenum: 16 nTPM
- colon: 11 nTPM
- rectum: 5.8 nTPM
- gallbladder: 2.6 nTPM
Single-cell type
- colonocytes: 109 nCPM
- enterocytes: 104 nCPM
- proximal tubule cells: 78 nCPM
- foveolar cells: 39 nCPM
- enteric transient amplifying cells: 27 nCPM
- enteric stem cells: 26 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- medulla oblongata: 0.2 nTPM
- midbrain: 0.2 nTPM
- cerebellum: 0.1 nTPM
- choroid plexus: 0.1 nTPM
- hypothalamus: 0.1 nTPM
- spinal cord: 0.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.27
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- monoatomic ion transport
- negative regulation of cGMP-mediated signaling
- protein localization to plasma membrane
- receptor guanylyl cyclase signaling pathway
- response to toxic substance
- water transport
Molecular functions
- ion channel inhibitor activity
- protein-membrane adaptor activity
- signaling receptor binding
- ubiquitin-specific protease binding
- guanylate cyclase inhibitor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NHERF4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NHERF4 as an antibody target. Whether an autoantibody or antibody against NHERF4 could matter depends on whether native NHERF4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NHERF4 is annotated at the cell surface, where native NHERF4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label NHERF4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...